glp 1 agonist metformin Synergistic effects of with liraglutide against endothelial dysfunction through GLP-1 receptor and PKA signalling pathway Role of GLP-1 Receptor Agonists
Description
Back US FDA (8 Nov 2023) FDA approves new medication for chronic weight management'
Moreover, several novel co-agonists are currently under development, including retatrutide, a triple GIP/GLP-1/glucagon receptor co-agonist
5f, g, Supplementary Table 4)
For example, tirzepatide, marketed as Mounjaro for diabetes and Zepbound for weight loss, is a dual agonist, combining GLP1 and GIP receptor activity
[DOI] [PubMed] [Google Scholar] 141.Finan B, Clemmensen C, Zhu Z, et al
